MBIO has been in the news 563% more than usual
Jun 21, 2024, 6:32 PM
-17.80%
What does MBIO do
Mustang Bio, Inc., a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, focuses on developing cell and gene therapies for treating hematologic cancers, solid tumors, and rare genetic diseases. The company, which went public in 2017, collaborates with major medical centers like City of Hope and Fred Hutchinson Cancer Center to advance its pipeline in CAR T therapies and gene therapies.
MBIO has been in the news recently: Mustang Bio, Inc. sold 6,130,000 shares of common stock at $0.41 per share in a registered direct offering. Kaival Brands Innovations Group, Inc. saw a significant drop in shares after announcing a $6.0 million public offering.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.